RYAN CARPENTER: Open Payments
NPI 1639431927 · PORTSMOUTH, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,796 in 120 payments from 21 companies in 2025. Trend: 2023 $1,654 · 2024 $1,926 · 2025 $1,796
Food & beverage: $1,796
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $358 |
| Novo Nordisk Inc | 15 | $218 |
| PFIZER INC. | 12 | $166 |
| Gilead Sciences, Inc. | 9 | $138 |
| Otsuka America Pharmaceutical, Inc. | 10 | $136 |
| Lilly USA, LLC | 12 | $134 |
| Axsome Therapeutics, Inc. | 2 | $91 |
| AstraZeneca Pharmaceuticals LP | 6 | $89 |
| Lundbeck LLC | 5 | $85 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $74 |
Products named: REXULTI, VRAYLAR, NURTEC ODT, MOUNJARO, Auvelity, MAVYRET, Wegovy, UBRELVY.
Industry payments across OH — which companies pay providers there.
